Researchers evaluated the survival benefit of adding pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab –paclitaxel compared with chemotherapy alone. (Source: CancerNetwork)
from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2EtM91C
via IFTTT
Πέμπτη 13 Δεκεμβρίου 2018
Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Background To study whether thyroid function was associated with risk of hip or knee replacement due to primary osteoarthritis....
-
Abstract Background Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involve...
-
Denotation as Complex and Chronologically Extended: anvitābhidhāna in Śālikanātha's Vākyārthamātṛkā - I Abstract The two theories of ve...
-
To evaluate the quality of life (QoL) of patients with inoperable non-small cell lung cancer treated with conventionally fractionated radiot...
-
Abstract Cerebral and systemic organ microvascular pathologies coexist with human Alzheimer’s disease (AD) neuropathology. In this study, w...
-
Grandma covered cancer with make up for months Toowoomba Chronicle In Queensland more than 740 people are diagnosed with head and nec...
-
http://ift.tt/2s0PgaM
-
A descriptive study of clinical and radiological profile of longitudinal extensive myelitis in a tertiary hospital in Rajasthan, India Publi...
-
Thyroid Cancer Testing Market Expecting Worldwide Growth by 2017 – 2025 Medgadget (blog) Thyroid cancer is a type of cancer that oc...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου